Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA
| Location: | Maryland |
|---|---|
| Posted: | May 28, 2026 |
| Due: | Jun 8, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: | |
| Solicitation No: | 75N98026Q00467 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: May 28, 2026 04:30 pm EDT
- Original Response Date: Jun 08, 2026 09:00 am EDT
- Inactive Policy: Manual
- Original Inactive Date: Jun 08, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 7A21 - IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE)
-
NAICS Code:
- 51321 - Software Publishers
-
Place of Performance:
MD 20892USA
The MIB is conducting pre-clinical research on photoimmunotherapy (PIT), a targeted treatment approach that uses light activation to destroy specific cells. One area of this research focuses on IL2RA, a protein expressed on regulatory T cells (Tregs). These cells can reduce the immune system’s ability to respond effectively to cancer. The objective of this work is to selectively eliminate IL2RA-expressing Tregs in order to improve anti-cancer immune responses.
To support this research, MIB uses a transgenic mouse strain known as B-hIL2RA, which expresses the human form of IL2RA rather than the mouse form. Use of this model is essential because it enables evaluation of the same treatment materials, including antibodies, that are intended for future human application. As a result, this mouse strain has proven invaluable in the MIB’s ongoing research program.
The MIB is requesting to renew a licensing fee for transgenic mice, B-hIL2RA. B-hIL2RA transgenic mice.
- 6011 EXECUTIVE BLVD., SUITE 503L
- BETHESDA , MD 20892
- USA
- John Burton
- burtonjo@mail.nih.gov
- May 28, 2026 04:30 pm EDTPresolicitation (Original)
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
...ID: BPM057087 Title: Insurance Contracting and Credentialing for Rural Local Health Status: Open... ...
State Government of Maryland
Bid Due: 6/15/2026
...Follow Non-invasive Vascular Health Assessment Device Active Contract Opportunity Notice ID... OF THE ...
DEPT OF DEFENSE
Bid Due: 6/15/2026
...ID: BPM057500 Title: Health Risk Screening Tool - I/DD Status: Open Due / ...
State Government of Maryland
Bid Due: 6/26/2026
...ID: BPM056894 Title: Services - Life And Health Independent Review Organization Consulting...: Maryland ...
State Government of Maryland
Bid Due: 6/30/2026